Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Eye Infection Age: Adult |
Dose: Eye Drops – 1 drop Frequency: every one or two hours until control is achieved, then reduce frequency Note: instilled into the eye |
|
Indication: Ear Infection Age: Adult |
Dose: Ear Drops – 2 or 3 drops Frequency: every two or three hours until control is achieved, then reduce frequency Note: instilled into the ear |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Steroid responsive inflammatory conditions of the eye where prophylactic antibiotic treatment is required Age: Children |
Dose: Ophthalmic drops – 1 or 2 drops applied to each affected eye Frequency: Up to six times daily Duration: 7 days treatment duration Note: Maximum dose: 7 days treatment duration; Route: Ophthalmic |
Administration
- Apply 1/4 inch to lower lid
- Use 2-3 times daily
Side Effect
- Hypersensitivity reactions
- usually of the delayed type
- may occur leading to irritation
- burning
- stinging
- itching and dermatitis
- Corneal ulcer
- increased intraocular pressure leading to optic nerve damage
- reduced visual acuity and visual field defects
- Intensive or prolonged use of topical corticosteroids may lead to formation of posterior subcapsular cataracts
- In those diseases causing thinning of the cornea or sclera, corticosteroid therapy may result in thinning of the globe leading to perforation
- Mydriasis
- ptosis
- epithelial punctate keratitis and glaucoma
- Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas
- nasal irritation and dryness
- although sneezing
- headache
- lightheadedness
- urticaria
- nausea
- epistaxis
- rebound congestion
- bronchial asthma
- perforation of the nasal septum
- ulceration of the nasal septum
- anosmia
- parosmia and disturbance to sense of taste have also been reported
- Growth retardation has been reported in children receiving nasal corticosteroids at licensed doses
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Neuromuscular blockers
|
May increase respiratory depressant effects if significant systemic absorption
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Viral, Fungal Eye Conditions
|
Can worsen eye infections
|
|
Glaucoma, Herpetic Keratitis
|
Can worsen eye conditions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 25° C
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.